Rose Bengal disodium

孟加拉玫瑰红

Report date: 2024/05/31 18:11:15
NME

Base Information

Drug NameRose Bengal disodium
Drug Alias Name孟加拉红roseum bengalense natricum二碘曙红rosa bengala de sodiorose bengale sodique +[18] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionCell membrane modulatorsCell death stimulantsDendritic cells stimulants +[7] 
TargetsInterleukin-17Interleukin-22Interferons
Therapy Area/IndicationsUveal melanomaPlaque psoriasisMetastatic breast cancer +[20] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSaudi ArabiaNew Zealand +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesProvectus
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoProvectus Biopharmaceuticals IncVistagen Therapeutics Inc
Inactive CompaniesKing Saud UniversityH Lee Moffitt Cancer Center & Research InstituteProvectus Pharmaceuticals Inc
Active IndicationsUveal melanomaMetastatic breast cancerKeratitis +[13] 
Inactive IndicationsPlaque psoriasisSkin MelanomaCigarette Smoking +[7] 

Other Information

ATC CodeN/A
Related LinksKEGG